Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Canada · Delayed Price · Currency is CAD

1.910

+0.180 (10.40%)

Oct 15, 2026, 10:29 AM EST

TSXV:EBM Financials Overview

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	0.81	0.78	0.7	0.87	1.3	0.98
Revenue Growth	36.59%	11.39%	-19.11%	-33.22%	32.49%	36.57%
Gross Profit	0.57	0.55	0.45	0.55	0.9	0.46
Operating Income	-0.18	-0.27	-0.38	-0.47	-0.11	-0.57
Net Income	-0.23	-0.33	-0.46	-0.55	-0.15	-0.6
Earnings Per Share	-0.00	-0.00	-0.01	-0.01	-0.00	-0.01
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
United States (U.S.)	0.09	0.08	0.13	0.14	0.17	0.2
Asia	0.64	0.62	0.44	0.62	0.93	0.58
Canada	0.07	0.09	0.14	0.11	0.2	0.2
Total	0.81	0.78	0.7	0.87	1.3	0.98

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Investments	0	0.02	0	0.02	0.04	0.02
Total Debt	0.06	0.08	0.08	0.06	0.06	0.03
Net Cash (Debt)	-0.06	-0.06	-0.08	-0.04	-0.02	-0.01
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Operating Cash Flow	-0.01	0.02	-0.02	-0.02	-0	-0.12
Capital Expenditures	-	-	-	-	-0	-0.01
Free Cash Flow	-0.01	0.02	-0.02	-0.02	-0.01	-0.12
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Gross Margin	70.13%	70.45%	64.72%	63.18%	69.45%	46.72%
Operating Margin	-22.03%	-34.13%	-54.24%	-54.42%	-8.60%	-58.07%
Pretax Margin	-28.51%	-42.55%	-64.93%	-62.98%	-11.53%	-61.53%
Profit Margin	-28.51%	-42.55%	-64.93%	-62.98%	-11.53%	-61.52%
FCF Margin	-1.16%	2.47%	-2.17%	-1.95%	-0.56%	-12.41%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
P/FCF Ratio	-	2498.07	-	-	-	-
PS Ratio	146.74	61.66	96.16	63.49	66.25	102.52